Welcome to LookChem.com Sign In|Join Free

CAS

  • or

650579-66-1

Post Buying Request

650579-66-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

650579-66-1 Usage

Chemical classification

1-Piperazineethanimidamide, N-hydroxy-4-methyl-(9CI) is a derivative of piperazine, which is a heterocyclic organic compound.

Structure

It is an amide derivative, which means it contains a carbonyl group (C=O) bonded to a nitrogen atom (NH2).

Substituents

It contains a hydroxyl group (-OH) and a methyl group (-CH3) attached to the piperazine ring.

Chelating agent

It has the potential to act as a chelating agent, which means it can bind to metal ions and form complexes.

Check Digit Verification of cas no

The CAS Registry Mumber 650579-66-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,0,5,7 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 650579-66:
(8*6)+(7*5)+(6*0)+(5*5)+(4*7)+(3*9)+(2*6)+(1*6)=181
181 % 10 = 1
So 650579-66-1 is a valid CAS Registry Number.

650579-66-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Hydroxy-2-(4-methyl-1-piperazinyl)ethanimidamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:650579-66-1 SDS

650579-66-1Downstream Products

650579-66-1Relevant articles and documents

Receptor-Type Kinase Modulators and Methods of Use

-

Paragraph 0551, (2016/06/06)

The present invention provides compounds for modulating receptor kinase activity, particularly ephrin and EGFR, and methods of treating diseases mediated by receptor kinase activity utilizing the compounds and pharmaceutical compositions thereof. Diseases

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 650579-66-1